Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Carrie Manwaring
CONTACT
Lead
University of Texas Southwestern Medical Center
With
The study is an open-label, non-randomized, phase II basket therapeutic clinical trial. To determine the objective response rate of combination ligufalimab and cadonilimab in refractory and advanced hepatocellular carcinoma and biliary tract cancers.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
